Cameron sells LGND 51.18: Lemelson Capital Management Marks Flagship Fund's Second Anniversary
The fund's recent performance was driven in part by its significant short position in Ligand Pharmaceuticals (NASDAQ: LGND), a previous short position in World Wrestling Entertainment (NYSE: WWE), and its current long positions in Kulicke & Soffa ... ...
34 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home